biped.ai wins the Startup Champions Seed Night 2024
Share this article
Life sciences shone during the 13th edition of the Startup Champions Seed Night gathering more than 500 people at the Forum Rolex and online!
On 25 April 2024, 20 startups pitched their innovative plans to make an impact in the world of modern technology.
Co-organised by EPFL (EPFL Alumni and Startup Launchpad) & Venturelab, the Startup Champions Seed Night is an annual startup conference & pitch competition bringing together some of the most promising entrepreneurs from EPFL and the rest of Switzerland.
This year proved to be such a tough choice between all of these bright ideas presented by sharp innovators that the jury elected two winners: biped.ai and R2HOME!
AI Mobility harness for Blind People
Biped.ai makes the world accessible for blind and visually impaired people, using AI. The harness, worn on the shoulders, leverages advanced robotics and cameras to detect obstacles, provide indoor and outdoor navigation instructions, and describe the scene. It makes any place accessible in minutes. CEO Maël Fabien pitched on stage to present his technology.
Promising companies to watch
The evening was full of future champions in the field of life science. Get to know the Champions’ seed of the Swiss Health Valley:
Consulto is an early-stage start-up building the world-first virtual clinic specialised in team-based ambulatory care.
HepaVue has developed the world’s first virtual liver biopsy which will make liver disease diagnosis affordable, painless, safe and more accessible.
NanThermix SA offers a novel method to access and control temperature of living systems at the nanoscale.
Navintis: Saving lives by redefining the frontiers of precision neurovascular interventions.
NEOSENS tackles a global health concern, the unnecessary antibiotic treatment of 12% of all newborns in low and middle-income countries due to false sepsis diagnosis.
NovoViz designs and manufactures single-photon computational engines in different technology nodes for applications that demand high sensitivity and high speed but cannot handle large amounts of data.
PhenomX Health aims to improve the wellbeing, vitality and longevity of over 1 billion women globally.
Protonica aims to revolutionise cancer care through the advancement of proton therapy.
Source: EPFL Alumni